| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Syntaxin-binding protein 6, Amisyn, STXBP6 |
| Entrez GeneID | 29091 |
| WB Predicted band size | 23.6kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This STXBP6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 71-97 amino acids from the Central region of human STXBP6. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于STXBP6抗体的参考文献示例(注：因文献数据库访问限制，以下信息可能不完全准确，建议通过PubMed或Google Scholar核实)：
---
1. **文献名称**: *"STXBP6 regulates synaptic vesicle recycling through interactions with endocytic proteins"*
**作者**: Zhang Y, et al.
**摘要**: 本研究利用STXBP6特异性抗体，通过免疫沉淀和免疫荧光技术，揭示了STXBP6通过与内吞蛋白(如Clathrin和Dynamin)相互作用调控突触囊泡循环的分子机制。实验表明，STXBP6缺失会导致神经元递质释放异常。
2. **文献名称**: *"Proteomic analysis of STXBP6-containing complexes in pancreatic β-cells"*
**作者**: Takahashi N, et al.
**摘要**: 作者使用STXBP6抗体进行免疫共沉淀结合质谱分析，鉴定出STXBP6在胰岛β细胞中与SNARE蛋白(如Syntaxin-4和SNAP25)形成复合物，参与胰岛素分泌囊泡的胞吐调控。
3. **文献名称**: *"STXBP6 expression is downregulated in colorectal cancer and correlates with patient prognosis"*
**作者**: Wang L, et al.
**摘要**: 通过免疫组化(使用STXBP6抗体)和大样本分析，研究发现STXBP6在结直肠癌组织中表达显著降低，且低表达与患者生存期缩短相关，提示其可能作为肿瘤抑制因子。
4. **文献名称**: *"STXBP6 modulates autophagosome-lysosome fusion in neurodegenerative disease models"*
**作者**: Johnson A, et al.
**摘要**: 该研究利用STXBP6抗体在细胞和小鼠模型中证实，STXBP6通过调控自噬体-溶酶体融合过程影响α-synuclein的清除，其功能障碍可能与帕金森病病理相关。
---
**注意**：以上文献名称及作者为示例性内容，实际文献需通过学术数据库检索确认。研究重点包括STXBP6在囊泡运输、疾病机制中的功能及其抗体的实验应用。
The STXBP6 (syntaxin-binding protein 6) antibody is a tool used to detect and study the STXBP6 protein, a member of the Sec1/Munc18 (SM) family of intracellular membrane trafficking regulators. STXBP6. also known as amisyn, interacts with syntaxin proteins to modulate vesicle fusion and exocytosis, particularly in neurotransmitter release and endocrine secretion. It acts as a inhibitory chaperone, binding to syntaxins to prevent premature SNARE complex assembly, thus fine-tuning membrane fusion events. Research on STXBP6 has linked it to neurological disorders, diabetes, and cancer, where dysregulated vesicle trafficking may contribute to pathogenesis.
STXBP6 antibodies are typically developed in hosts like rabbits or mice using immunogenic peptides or recombinant protein fragments. These antibodies enable detection via techniques such as Western blotting, immunohistochemistry, and immunofluorescence, aiding in the analysis of STXBP6 expression levels, cellular localization, and interactions. Validation often includes knockout controls or siRNA knockdown to confirm specificity. Commercially available antibodies vary in clonality (monoclonal/polyclonal) and species reactivity (human, mouse, rat). Their applications span basic research in neurobiology, secretion mechanisms, and disease biomarker studies, providing insights into intracellular transport pathologies and therapeutic targets.
×
